Company

CRESCENT BIOPHARMA, INC. (CBIO)

Name: CRESCENT BIOPHARMA, INC. (CBIO) financial statements
Creator: SECfinAPI
License: https://www.secfinapi.com/terms

Standardized SEC financial data for CRESCENT BIOPHARMA, INC. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001253689 · NASDAQ · Pharmaceutical Preparations.

Income statement

USD	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$10.2M	$1.2M	$75K	$10K	—	$10.8M
R&D expense	$44.9M	$47.5M	$28.4M	$20.1M	—	$138.1M
SG&A expense	$16.7M	$17.1M	$19.1M	$19.2M	—	$25.4M
Operating income	-$51.5M	-$63.4M	-$47.4M	-$39.3M	—	-$152.6M
Pretax income	—	—	—	—	—	-$151.9M
Income tax	—	—	—	—	—	$2.0M
Net income	-$51.0M	-$63.4M	-$46.7M	-$36.9M	—	-$153.9M
EPS (diluted)	$-1.12	$-1.23	$-0.89	$-0.58	$-0.59	—

Standardized from CRESCENT BIOPHARMA, INC.'s SEC filings — per-share figures split-adjusted. Full history via the API.

Cash flow

USD	FY2019	FY2020	FY2021	FY2022	FY2023	FY2025
Operating cash flow	-$52.0M	-$39.2M	-$57.5M	-$46.5M	-$34.9M	-$71.5M
Capital expenditures	$145K	$69K	$15K	$84K	$21K	$919K
Free cash flow	-$52.1M	-$39.3M	-$57.5M	-$46.5M

Get CBIO data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CBIO/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CBIO/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View CBIO filings on SEC EDGAR →